NR3C2 and cardiac hypertrophy: Interestingly, pharmacological MR antagonism decreased the accumulation and activation of CD4+ and CD8+ T cells in the murine heart and T cells specific MR-knockout mice displayed reduced cardiac hypertrophy, fibrosis, and dysfunction (78).